Houston, Texas
United States
9
2021-09-30
5
2021-09-07
These are the the leading inventors for applications assigned to DNATRIX INC.:
DNATRIX INC. based in Houston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#2 | 2020-12-03 ✅ Patent 11,110,137 granted on 2021-09-07Combination therapy for treatment of brain cancers
#3 | 2020-10-22 ✅ Patent 11,065,285 granted on 2021-07-20Biomarkers and combination therapies using oncolytic virus and immunomodulation
#4 | 2019-07-04 ✅ Patent 11,090,344 granted on 2021-08-17Adenovirus and immunomodulator combination therapy
#5 | 2019-03-28ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#6 | 2016-12-08 ✅ Patent 10,016,470 granted on 2018-07-10Oncolytic adenoviruses for cancer treatment
#7 | 2016-10-06Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)
#8 | 2016-05-26TREATMENT OF BRAIN CANCER WITH ONCOLYTIC ADENOVIRUS
#9 | 2014-12-25 ✅ Patent 10,238,698 granted on 2019-03-26Biomarkers and combination therapies using oncolytic virus and immunomodulation
Also check out DNATRIX, INC.'s (Houston, United States) applicant profile with 5 patent applications submitted.
85243 ⎘